Rani Therapeutics Holdings recently announced a collaboration and license agreement with Chugai Pharmaceutical for the joint development and commercialization of an oral product combining Rani’s ...
Nano-cap biotherapeutics company Rani Therapeutics (NASDAQ:RANI) surged over 200% on Friday after the drug developer announced a licensing deal with Japanese pharma giant Chugai Pharmaceutical ...
Biotech stocks are lighting up the tape today, with several clinical-stage companies posting double-digit gains on fresh catalysts. From earnings beats to promising trial data and billion-dollar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback